🇺🇸 FDA
Pipeline program

Telaprevir and Sofosbuvir

20132125

Phase 2 small_molecule completed

Quick answer

Telaprevir and Sofosbuvir for Hepatitis C, Chronic is a Phase 2 program (small_molecule) at VERTEX PHARMACEUTICALS INC / MA with 1 ClinicalTrials.gov record(s).

Program details

Company
VERTEX PHARMACEUTICALS INC / MA
Indication
Hepatitis C, Chronic
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials